1 | ACEi | - | - | - | - | [2] 66 66, 224 |
2 | Acetate | [1] Acetate Acetate | - | - | - | [41] 1 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 |
3 | Adrenal cortical hormone | - | - | - | - | [1] 224 224 |
4 | Adrenergic receptor binder (ARB) | - | - | - | - | [1] 224 224 |
5 | Angiotensin | [1] Angiotensin II Angiotensin II | [2] D00150
D00150
,
D02014
| [2] AGTR1 AGTR1, AGTR2 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [7] 17 17, 19, 46, 66, 86, 222, 224 |
6 | Angiotensin-converting enzyme (ACE) inhibitor | [1] Angiotensin II Angiotensin II | [2] D00150
D00150
,
D02014
| [2] AGTR1 AGTR1, AGTR2 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 224 224 |
7 | Angiotensin-converting enzyme inhibitor(ACEI) | [1] Angiotensin II Angiotensin II | [2] D00150
D00150
,
D02014
| [2] AGTR1 AGTR1, AGTR2 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 224 224 |
8 | Benazepril | [1] Benazepril Benazepril | [1] D07499
D07499
| [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [4] 49 49, 57, 218, 224 |
9 | Benazepril Hydrochloride Tablets | [1] Benazepril Benazepril | [1] D07499
D07499
| [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 224 224 |
10 | Calcium | [1] Calcium Calcium | - | - | - | [27] 6 6, 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 156, 214, 215, 222, 224, 235, 265, 274, 298, 299 |
11 | Chinese herbs based on syndrome differentiation | - | - | - | - | [1] 224 224 |
12 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [44] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 |
13 | Cyclophosphamide(CTX) | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [1] 224 224 |
14 | Dipyridamole | [1] Dipyridamole Dipyridamole | [1] D00302
D00302
| [2] PDE4A PDE4A, PDE5A 💬 | [6] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [6] 46 46, 49, 51, 66, 96, 224 |
15 | Dipyridamole Tab 25 MG | [1] Dipyridamole Dipyridamole | [1] D00302
D00302
| [2] PDE4A PDE4A, PDE5A 💬 | [6] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 224 224 |
16 | Glycosides Of Tripterygium Wilfordii Hook(GTW) | [1] Tripterygium wilfordii whole Tripterygium wilfordii whole | - | - | - | [1] 224 224 |
17 | Gold | [1] Gold Gold | - | - | - | [43] 2 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318 |
18 | Heparin | [1] Heparin Heparin | [1] D07510
D07510
| [1] SERPINC1 SERPINC1 💬 | [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [11] 47 47, 60, 70, 84, 107, 224, 226, 280, 299, 316, 317 |
19 | Huaiqinhuang | - | - | - | - | [1] 224 224 |
20 | Hydroxychloroquine | [1] Hydroxychloroquine Hydroxychloroquine | [1] D08050
D08050
| - | - | [27] 13 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 |
21 | Immunosuppressant | - | - | - | - | [1] 224 224 |
22 | Leflunomide | [1] Leflunomide Leflunomide | [1] D00749
D00749
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [12] 11 11, 40, 46, 49, 53, 66, 107, 162, 224, 270, 271, 300 |
23 | Leflunomide(LEF) | [1] Leflunomide Leflunomide | [1] D00749
D00749
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 224 224 |
24 | Low Molecular Weight Heparin Calcium Injection | [2] Calcium Calcium, Heparin | [1] D07510
D07510
| [1] SERPINC1 SERPINC1 💬 | [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 224 224 |
25 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [1] D00407
D00407
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [46] 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 |
26 | Mizoribine | [1] Mizoribine Mizoribine | [1] D01392
D01392
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [8] 46 46, 49, 51, 53, 66, 94, 222, 224 |
27 | MMF | - | - | - | - | [16] 13 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 107, 162, 222, 224, 226, 299 |
28 | Mycophenolate | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [36] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
29 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [2] D00752
D00752
,
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [34] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
30 | Mycophenolate mofetil(MMF) | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [2] D00752
D00752
,
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | [1] 224 224 |
31 | Prednisone | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [45] 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 |
32 | Prednisone acetate | [3] Acetate Acetate, Prednisone, Prednisone acetate | [2] D00473
D00473
,
D08416
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 46 46, 49, 224 |
33 | Prednisone Acetate Tablets | [3] Acetate Acetate, Prednisone, Prednisone acetate | [2] D00473
D00473
,
D08416
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 224 224 |
34 | Qi-Ji Shen-Kang formula | - | - | - | - | [1] 224 224 |
35 | Sulfate | [1] Sulfate ion Sulfate ion | - | - | - | [27] 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299 |
36 | Sulfotanshinone Sodium Injection | - | - | - | - | [1] 224 224 |
37 | Tacrolimus | [1] Tacrolimus Tacrolimus | [2] D00107
D00107
,
D08556
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [34] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
38 | Tripterygium | [1] Tripterygium wilfordii whole Tripterygium wilfordii whole | - | - | - | [8] 46 46, 66, 67, 96, 162, 222, 224, 271 |
39 | Tripterygium Wilfordii | [1] Tripterygium wilfordii whole Tripterygium wilfordii whole | - | - | - | [6] 46 46, 66, 67, 222, 224, 271 |
40 | Tripterygium wilfordii polyglycosidium | [1] Tripterygium wilfordii whole Tripterygium wilfordii whole | - | - | - | [1] 224 224 |
41 | Valsartan | [1] Valsartan Valsartan | [1] D00400
D00400
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [7] 57 57, 58, 66, 75, 218, 222, 224 |
42 | Yu-Shen formula | - | - | - | - | [1] 224 224 |
43 | Zhu-Bai formula | - | - | - | - | [1] 224 224 |